Bioethicists, biomedical policy experts and lawyers, physicians, nursing and allied health students as well as science educators will find this book helpful and engaging in exploring the complexities of modern evolutionary, genetic and biomedical data.

Table of Contents

• Preface
• Acknowledgments
• Author
• SECTION I: Bioethics of Biotechnology
• 1. A Bioethics of Biotechnology
• Introductory comment
• The biotechnology of history
• The nature of science and biotechnology
• What then is the bioethics of biotechnology?
• SECTION II: Bioethics and Genomics
• 2. Biotechnology and Bioethics
• Introductory comment
• Autonomy
• Confidentiality and privacy
• Informed consent
• Genetic stigmatization and essentialism
• 3. Direct-to-Consumer Genetic Testing
• An introductory comment
• DTC genetic tests: Dialectic analysis-implications for personalized medicine
• Preliminary conclusion
• SECTION III: Regulatory Policy, Law and Biotechnology
• 4. The Global Regulatory Pathways of Biologics
• An introductory comment
• The emergence and development of biologics regulatory pathways in the United States
• The emergence of biologics regulatory pathways
• Features of biologics and biotechnology research
• The prospects of biosimilars
• The biotechnology landscape in Canada
• Patent, data, and market exclusivities of biologics
• Bioethics and some regulatory hurdles
• 5. Biotechnology in the Court of Law
• Association for molecular pathology versus myriad genetics
• SECTION IV: Gene Modifications and Bioethics
• 6. Bioengineering and the Idea of Precision Medicine
• What is gene editing?
• Characteristics of gene editing tools
• Types of gene modification biotechnologies
• Classifications and applications of gene editing biotechnologies
• Some ethical quagmires of gene modifications
• 7. Policy, Bioethics, and Bioengineering
• Precautionary approach
• Moratoria approach
• Noninterventionist or proactionary approach
• 8. Some Perspectives and Conclusion